Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Influenza

Free Subscription Articles published in Cell Retrieve available abstracts of 45 articles: HTML format

Single Articles

June 2025
1. DHENNI R, Hoppe AC, Reynaldi A, Kyaw W, et al
   Macrophages direct location-dependent recall of B cell memory to vaccination.
   Cell. 2025;188:3477-3496.
   PubMed     Abstract available
   
   
   
2. PEKAR JE, Lytras S, Ghafari M, Magee AF, et al
   The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2.
   Cell. 2025;188:3167-3183.
   PubMed     Abstract available
   
   
   
3. STEVENS J, Culberson E, Kinder J, Ramiriqui A, et al
   Microbiota-derived inosine programs protective CD8(+) T cell responses against influenza in newborns.
   Cell. 2025 Jun 3:S0092-8674(25)00563-X. doi: 10.1016/j.cell.2025.
   PubMed     Abstract available
   
   
   March 2025
4. JIANG S, Wu F
   Global surveillance and countermeasures for ACE2-using MERS-related coronaviruses with spillover risk.
   Cell. 2025;188:1465-1468.
   PubMed     Abstract available
   
   
   
5. CHEN J, Zhang W, Li Y, Liu C, et al
   Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor.
   Cell. 2025;188:1729-1742.
   PubMed     Abstract available
   
   
   
6. XING L, Liu Z, Wang X, Liu Q, et al
   Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target.
   Cell. 2025;188:1297-1314.
   PubMed     Abstract available
   
   
   February 2025
7. WANG E, Cohen AA, Caldera LF, Keeffe JR, et al
   Designed mosaic nanoparticles enhance cross-reactive immune responses in mice.
   Cell. 2025;188:1036-1050.
   PubMed     Abstract available
   
   
   January 2025
8. SONG H, Hao T, Han P, Wang H, et al
   Receptor binding, structure, and tissue tropism of cattle-infecting H5N1 avian influenza virus hemagglutinin.
   Cell. 2025 Jan 22:S0092-8674(25)00048-0. doi: 10.1016/j.cell.2025.
   PubMed     Abstract available
   
   
   December 2024
9. PASQUESI GIM, Allen H, Ivancevic A, Barbachano-Guerrero A, et al
   Regulation of human interferon signaling by transposon exonization.
   Cell. 2024;187:7621-7636.
   PubMed     Abstract available
   
   
   
10. ROSEN LE, Tortorici MA, De Marco A, Pinto D, et al
    A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification.
    Cell. 2024;187:7196-7213.
    PubMed     Abstract available
    
    
    November 2024
11. XIANG Y, Xu J, McGovern BL, Ranzenigo A, et al
    Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy.
    Cell. 2024;187:6966-6980.
    PubMed     Abstract available
    
    
    October 2024
12. FITZGERALD ML, Cohen AK, Jaudon TW, Vogel JM, et al
    A call from patient-researchers to advance research on long COVID.
    Cell. 2024;187:5490-5496.
    PubMed     Abstract available
    
    
    
13. COHEN AA, Keeffe JR, Schiepers A, Dross SE, et al
    Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals.
    Cell. 2024;187:5554-5571.
    PubMed     Abstract available
    
    
    September 2024
14. PELUSO MJ, Deeks SG
    Mechanisms of long COVID and the path toward therapeutics.
    Cell. 2024 Sep 25:S0092-8674(24)00886-9. doi: 10.1016/j.cell.2024.
    PubMed     Abstract available
    
    
    
15. CRITS-CHRISTOPH A, Levy JI, Pekar JE, Goldstein SA, et al
    Genetic tracing of market wildlife and viruses at the epicenter of the COVID-19 pandemic.
    Cell. 2024;187:5468-5482.
    PubMed     Abstract available
    
    
    
16. RAPPUOLI R, Alter G, Pulendran B
    Transforming vaccinology.
    Cell. 2024;187:5171-5194.
    PubMed     Abstract available
    
    
    
17. MBOOWA G, Tessema SK, Christoffels A, Ndembi N, et al
    Africa in the era of pathogen genomics: Unlocking data barriers.
    Cell. 2024;187:5146-5150.
    PubMed     Abstract available
    
    
    
18. HOLMES EC, Krammer F, Goodrum FD
    Virology-The next fifty years.
    Cell. 2024;187:5128-5145.
    PubMed     Abstract available
    
    
    August 2024
19. JIA X, Crawford JC, Gebregzabher D, Monson EA, et al
    High expression of oleoyl-ACP hydrolase underpins life-threatening respiratory viral diseases.
    Cell. 2024;187:4586-4604.
    PubMed     Abstract available
    
    
    
20. KNOLL R, Helbig ET, Dahm K, Bolaji O, et al
    The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation.
    Cell. 2024;187:4318-4335.
    PubMed     Abstract available
    
    
    July 2024
21. MORATORIO G, Kesavardhana S, Lakdawala SS, Poon L, et al
    H5N1 influenza: Urgent questions and directions.
    Cell. 2024 Jul 26:S0092-8674(24)00784-0. doi: 10.1016/j.cell.2024.
    PubMed     Abstract available
    
    
    May 2024
22. HARTMANN JA, Cardoso MR, Talarico MCR, Kenney DJ, et al
    Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses.
    Cell. 2024;187:2393-2410.
    PubMed     Abstract available
    
    
    April 2024
23. WAYNE CJ, Blakney AK
    Self-amplifying RNA COVID-19 vaccine.
    Cell. 2024;187:1822-1822.
    PubMed     Abstract available
    
    
    February 2024
24. QU P, Xu K, Faraone JN, Goodarzi N, et al
    Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants.
    Cell. 2024;187:585-595.
    PubMed     Abstract available
    
    
    
25. ZHANG L, Kempf A, Nehlmeier I, Cossmann A, et al
    SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.
    Cell. 2024;187:596-608.
    PubMed     Abstract available
    
    
    December 2023
26. MATTESON NL, Hassler GW, Kurzban E, Schwab MA, et al
    Genomic surveillance reveals dynamic shifts in the connectivity of COVID-19 epidemics.
    Cell. 2023;186:5690-5704.
    PubMed     Abstract available
    
    
    November 2023
27. MEIJERS M, Ruchnewitz D, Eberhardt J, Luksza M, et al
    Population immunity predicts evolutionary trajectories of SARS-CoV-2.
    Cell. 2023;186:5151-5164.
    PubMed     Abstract available
    
    
    October 2023
28. SCHMIDT N, Ganskih S, Wei Y, Gabel A, et al
    SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.
    Cell. 2023;186:4834-4850.
    PubMed     Abstract available
    
    
    
29. BOUHADDOU M, Reuschl AK, Polacco BJ, Thorne LG, et al
    SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
    Cell. 2023;186:4597-4614.
    PubMed     Abstract available
    
    
    
30. WIMMERS F, Burrell AR, Feng Y, Zheng H, et al
    Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth.
    Cell. 2023;186:4632-4651.
    PubMed     Abstract available
    
    
    
31. WONG AC, Devason AS, Umana IC, Cox TO, et al
    Serotonin reduction in post-acute sequelae of viral infection.
    Cell. 2023 Oct 9:S0092-8674(23)01034-6. doi: 10.1016/j.cell.2023.
    PubMed     Abstract available
    
    
    September 2023
32. HONCE R, Schultz-Cherry S
    Looking beyond the H5 avian influenza viruses.
    Cell. 2023;186:4003-4004.
    PubMed     Abstract available
    
    
    August 2023
33. SAWITZKI B
    Haunting innate immune memories of COVID-19.
    Cell. 2023;186:3753-3755.
    PubMed     Abstract available
    
    
    
34. CHEONG JG, Ravishankar A, Sharma S, Parkhurst CN, et al
    Epigenetic memory of coronavirus infection in innate immune cells and their progenitors.
    Cell. 2023;186:3882-3902.
    PubMed     Abstract available
    
    
    
35. SUN H, Li H, Tong Q, Han Q, et al
    Airborne transmission of human-isolated avian H3N8 influenza virus between ferrets.
    Cell. 2023 Aug 24:S0092-8674(23)00891-7. doi: 10.1016/j.cell.2023.
    PubMed     Abstract available
    
    
    
36. LACRAMPE A, Hu F
    Unveiling TMEM106B: SARS-CoV-2's secret entrance to the cell.
    Cell. 2023;186:3329-3331.
    PubMed     Abstract available
    
    
    
37. BAGGEN J, Jacquemyn M, Persoons L, Vanstreels E, et al
    TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry.
    Cell. 2023;186:3427-3442.
    PubMed     Abstract available
    
    
    July 2023
38. FALSEY AR, Walsh EE
    Respiratory syncytial virus Prefusion F vaccine.
    Cell. 2023;186:3137-3137.
    PubMed     Abstract available
    
    
    
39. TEGALLY H, Wilkinson E, Tsui JL, Moir M, et al
    Dispersal patterns and influence of air travel during the global expansion of SARS-CoV-2 variants of concern.
    Cell. 2023;186:3277-3290.
    PubMed     Abstract available
    
    
    May 2023
40. ZOST SJ, Carnahan RH
    A budding new approach strengthens an important message.
    Cell. 2023;186:2283-2285.
    PubMed     Abstract available
    
    
    
41. ARIETA CM, Xie YJ, Rothenberg DA, Diao H, et al
    The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection.
    Cell. 2023;186:2392-2409.
    PubMed     Abstract available
    
    
    
42. HOFFMANN MAG, Yang Z, Huey-Tubman KE, Cohen AA, et al
    ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines.
    Cell. 2023;186:2380-2391.
    PubMed     Abstract available
    
    
    
43. AHN M, Chen VC, Rozario P, Ng WL, et al
    Bat ASC2 suppresses inflammasomes and ameliorates inflammatory diseases.
    Cell. 2023;186:2144-2159.
    PubMed     Abstract available
    
    
    March 2023
44. OUDIT GY, Wang K, Viveiros A, Kellner MJ, et al
    Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic.
    Cell. 2023;186:906-922.
    PubMed     Abstract available
    
    
    February 2023
45. DADONAITE B, Crawford KHD, Radford CE, Farrell AG, et al
    A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike.
    Cell. 2023 Feb 13:S0092-8674(23)00103-4. doi: 10.1016/j.cell.2023.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.